Welcome to LookChem.com Sign In|Join Free

CAS

  • or

120503-69-7

Post Buying Request

120503-69-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120503-69-7 Usage

Uses

Different sources of media describe the Uses of 120503-69-7 differently. You can refer to the following data:
1. N6-Cyclopropyl-9H-purine-2,6-diamine is an impurity of Abacavir Sulfate (A105000), a nucleoside reverse transcriptase inhibitor.
2. N6-Cyclopropyl-9H-purine-2,6-diamine is an impurity of Abacavir Sulfate (A105000), a nucleoside reverse transcriptase inhibitor (1,2,3).
3. 2-Amino-6-cyclopropylamino-9H-purine is used in preparation of Purine derivatives as AMPK activating compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 120503-69-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,5,0 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 120503-69:
(8*1)+(7*2)+(6*0)+(5*5)+(4*0)+(3*3)+(2*6)+(1*9)=77
77 % 10 = 7
So 120503-69-7 is a valid CAS Registry Number.

120503-69-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-N-cyclopropyl-7H-purine-2,6-diamine

1.2 Other means of identification

Product number -
Other names 2-amino-6-cyclopropylaminoropurine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:120503-69-7 SDS

120503-69-7Relevant articles and documents

Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)

-

Paragraph 0049-0050, (2014/10/16)

The present invention relates to a method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) and the use of the compounds in the prevention or treatment of disease, including pre-diabetes, type 2 diabetes, syndrome X, metabolic syndrome and obesity.

An efficient, general asymmetric synthesis of carbocyclic nucleosides: Application of an asymmetric aldol/ring-closing metathesis strategy

Crimmins,King,Zuercher,Choy

, p. 8499 - 8509 (2007/10/03)

A general and efficient synthesis of carbocyclic and hexenopyranosyl nucleosides has been developed. The strategy combines three key transformations: an asymmetric aldol addition to establish the relative and absolute configuration of the pseudosugar, a ring-closing metathesis to construct the pseudosugar ring, and a Trost-type palladium(0)-mediated substitution to assemble the pseudosugar and the aromatic base. Carbovir, abacavir, and their 2'-methyl derivatives as well as hexenopyranosyl nucleoside analogues have been prepared by this sequence.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 120503-69-7